|
Symbol
|
RMA0EV | RMA72V | RMBQ5V | RMA7JV | RMBAIV | PKRRCH | ABUBTQ | RMAHCV | CKNBKB | CMDBKB | RMAWUV | POARCH | POTRCH | Z0AQXZ | ACGFTQ | RMBV1V | RMALFV | MBUDJB | Z0AU9Z | RMACWV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible with European Knock-In | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible with European Knock-In | Callable Multi Defender Vonti |
|
Basiswert
|
Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Alcon / Lonza Group N / Ypsomed Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Bachem Hldg. AG / Sonova Hldg. AG / Ypsomed Hldg. AG | Alcon / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Givaudan / Holcim/Amrize Basket / Nestlé S.A. / Ypsomed Hldg. AG | Bachem Hldg. AG / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Straumann Hldg. AG / VAT Group / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Sonova Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Galderma Group AG / Sandoz Group AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / VAT Group / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Sandoz Group AG / Ypsomed Hldg. AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
15.06.2026 | 31.08.2026 | 17.11.2026 | 21.12.2026 | 30.12.2026 | 30.06.2026 | 30.12.2026 | 05.01.2027 | 23.06.2026 | 17.07.2026 | 25.01.2027 | 31.07.2026 | 07.08.2026 | 19.08.2027 | 03.09.2026 | 01.03.2027 | 28.08.2026 | 28.09.2026 | 03.09.2027 | 31.03.2027 |
| Geld | 28.000 | 81.90 | 39.300 | 98.60 | 49.600 | 100.32 | 93.52 | 99.20 | 71.21 | 93.79 | 88.30 | 100.35 | 64.10 | - | 70.89 | 94.80 | 97.30 | - | - | - |
| Brief | - | - | - | 100.20 | - | - | 94.32 | 100.60 | - | - | - | - | - | - | - | 96.20 | 98.70 | - | - | - |